Supportive of this role of ALDOA are other studies showing that silencing of ALDOA increased E-cadherin (epithelial marker) and decreased N-cadherin (mesenchymal marker) in pancreatic cancer (236) and bladder cancer cell lines (237). Here, ALDOA is linked to urinary bladder carcinoma.